Max Healthcare Institute (MAXHEALTH) Fundamentals 2026 — P/E 72.9x, Revenue Analysis | SniperIQ
Max Healthcare Institute (MAXHEALTH) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹1.05 Lakh Crore, trading at ₹1081.65 on the BSE. This SniperIQ fundamentals page covers Max Healthcare Institute's valuation (P/E 72.9x, P/B 9.8x), profitability (net margin 17.2%), revenue (₹8,373 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Max Healthcare Institute's market cap?
Max Healthcare Institute (MAXHEALTH) has a market capitalization of approximately ₹1.05 Lakh Crore, trading at ₹1081.65 on the BSE. Market cap moves with the live share price.
What is Max Healthcare Institute's P/E ratio?
Max Healthcare Institute's trailing twelve-month P/E ratio is 72.9x, with a price-to-book (P/B) of 9.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Max Healthcare Institute?
Max Healthcare Institute runs a net profit margin of 17.2%, a gross margin of 63.9%, and an operating margin of 26.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Max Healthcare Institute generate?
Max Healthcare Institute reported revenue of ₹8,373 Crore for fiscal year 2026, with net income of ₹1,442 Crore and earnings per share (EPS) of 14.84. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Max Healthcare Institute pay a dividend?
Max Healthcare Institute offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Max Healthcare Institute financially healthy?
Max Healthcare Institute carries a debt-to-equity ratio of 0.32x and a current ratio of 0.89x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Max Healthcare Institute a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Max Healthcare Institute (MAXHEALTH) the key facts are: market cap ₹1.05 Lakh Crore, P/E 72.9x, revenue ₹8,373 Crore, 52-week range 903.5-1301.95. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Max Healthcare Institute's full fundamentals live
Get Max Healthcare Institute's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.